PoliticsEXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say
The United States is developing rules for pharmaceutical companies investing in China that would likely preserve their ability to make most licensing agreements involving Chinese drugs, according to three people briefed on the process.
R
EXCLUSIVE: US weighs allowing most pharma licensing deals with China, sources say
Politics